10X Genomics deliver on their promise to have GemCode ready to ship in second quarter, just!

10X Genomics were the talk of AGBT this year with the announcement of their GemCode Platform. By and large, most people seem to agree that longer reads are a good thing. What they tend to be a little less enthusiastic about is having to pay for a new machine to get them. And that’s where 10X have come in and gotten a lot of people very excited.

So what is GemCode? It’s a platform that upgrades short read sequencers (configured to be compatible with Illumina systems) to deliver ‘Linked-Reads’. It is a unique molecular barcoding and analysis platform that consists of instrumentation, reagents and software, which delivers long-range information, including haplotype phasing, structural variation, and other critical genomic information.

“Broad researchers are excited to start generating 10X data,” said Stacey Gabriel, Director, Genomics Platform at the Broad Institute. “With the GemCode Platform now installed, we will soon deliver Linked-Reads for a range of applications including structural variant detection and haplotype phasing. This technology will be a great addition to the suite of sequencing offerings we make available to the scientific community.”

It certainly sounds very promising. So if you’re in the market for an upgrade, GemCode might be an interesting option to look into. If anything, they’re true to their word. At AGBT they promised they’d be ready to ship in the second quarter, and here we are as they made their announcement on June 30th.

“10X Genomics is enabling researchers to routinely access genomic information that was previously difficult or impossible to obtain,” said Serge Saxonov, CEO of 10X Genomics. “At AGBT, we committed to commercial shipments of the GemCode Platform in the second quarter of this year, and are very pleased to have met that goal with shipments to multiple customers. We are well on our way to changing the definition of sequencing.”